University Hospital Helsinki
Welcome,         Profile    Billing    Logout  
 5 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Strbian, Daniel
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Terminated
3
535
Europe, Canada, Japan, US, RoW
BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo
Remedy Pharmaceuticals, Inc.
Brain Edema, Stroke, Acute
08/23
08/23
TenCRAO, NCT04526951: TENecteplase in Central Retinal Artery Occlusion Stuy (S)

Recruiting
3
78
Europe, RoW
Intravenous injection of Tenecteplase and one dose of placebo tablet, Metalyse, One tablet of Acetylsalicylic Acid and one dose of IV placebo, Aspirin
Oslo University Hospital
Central Retinal Artery Occlusion
03/25
03/25
TEMPO-2, NCT02398656: A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

Completed
3
1274
Europe, Canada, RoW
Tenecteplase, TNK-tPA, Antiplatelet treatment, ASA, Clopidogrel
University of Calgary
Stroke, Acute
01/24
04/24
TECNO, NCT05499832: Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

Recruiting
3
156
Europe
Tenecteplase
Insel Gruppe AG, University Hospital Bern
Ischemic Stroke
07/25
10/25
NCT05814523: To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

Withdrawn
3
70
Europe, RoW
Ganaxolone, Placebo, Standard of care
Marinus Pharmaceuticals
Refractory Status Epilepticus
08/24
08/24
PLATO, NCT05291637: Posterior cerebraL ArTery Occlusion Study

Completed
N/A
1282
Europe, US
Boston Medical Center, Heidelberg University
Stroke, Acute Ischemic
05/22
01/23
ELAN, NCT03148457: Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial

Completed
N/A
2013
Europe, Japan, RoW
Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®), Late treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)
Insel Gruppe AG, University Hospital Bern
Ischaemic Stroke
12/22
05/23
SWITCH, NCT02258919: Decompressive Hemicraniectomy in Intracerebral Hemorrhage

Completed
N/A
201
Europe
Decompressive craniectomy (DC) and best medical treatment, Best medical treatment
Insel Gruppe AG, University Hospital Bern
Cerebral Hemorrhage
10/23
05/24
SPINNERS, NCT05458908: ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS

Recruiting
N/A
252
Europe, US
Non-contrast cranial MDCT head scan, Non-contrast syngo DynaCT Sine Spin head scan and application software
University Hospital, Basel, Switzerland, Siemens Healthineers AG
Stroke
04/25
07/25
DISTAL, NCT05029414: EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke

Active, not recruiting
N/A
543
Europe, RoW
Endovascular Therapy
University Hospital, Basel, Switzerland, Swiss National Fund for Scientific Research, Stryker Neurovascular, Penumbra Inc., Medtronic, Phenox GmbH, Rapid Medical, Gottfried und Julia Bangerter-Rhyner-Stiftung
Acute Ischemic Stroke
10/24
06/25
SENSEII/AROUSE, NCT05839418: Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status Epilepticus (SENSE-II/AROUSE)

Recruiting
N/A
3000
Europe
Erasme University Hospital
Status Epilepticus
12/28
12/28

Download Options